We found that an increasing number of CYP2C8/9 *3/*1/*2/*1 haplotype alleles and especially CYP2C8*3 alleles was associated with increased hazard of early breast cancer-related events in tamoxifen-treated patients. The gene discussed is CYP2C8; the disease is breast carcinoma.